Summary
This prediction ended on 22.11.18 with a price of €62.62. Massive losses of -39.98% were the result for the BUY prediction by tbackenh. tbackenh has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | -9.216% | -9.216% | 61.676% | -37.168% |
| iShares Core DAX® | -1.424% | 8.918% | 7.311% | 49.214% |
| iShares Nasdaq 100 | 3.274% | 16.275% | 36.651% | 97.344% |
| iShares Nikkei 225® | 1.745% | 16.239% | 46.602% | 64.976% |
| iShares S&P 500 | 1.447% | 10.913% | 27.166% | 68.765% |
Comments by tbackenh for this prediction
In the thread Bayer AG diskutieren
Bayer
Wie im Langfristchart erkennbar, bewegte sich die Aktie des Chemie- und Pharma-Riesen von Ende 2011 bis April 2015 stetig aufwärts. Danach folgte eine Abwärtsbewegung. 2017 sehen wir eine kleine, volatilere Auf- und Abwärtsphase. Und genau diese könnte durch die Verteidigung des 256-Tage-GD nun zugunsten einer weiteren Aufwärtsbewegung beendet sein.